School of Medicine

The lab of Quing Zhu at the McKelvey School of Engineering has developed an imaging system that helps differentiate residual cancerous tissue from recovered healthy tissue after treatment in patients with rectal cancer, the third-most common cancer type in the U.S.

Farshid Guilak, the Mildred B. Simon Research Professor of Orthopaedic Surgery and co-director of the Washington University Center of Regenerative Medicine, has received the 2021 Elizabeth Winston Lanier Kappa Delta Award for his research involving the treatment of arthritic joints.

Public participation is critical to the success of medical research. Yet recruiting volunteers for trials is increasingly challenging. New Washington University research suggests the widening ideological gap in the U.S. may be to blame.

Wearing masks, social distancing and frequent hand-washing have kept in-school COVID-19 transmission low, according to results of a pilot study in Missouri involving the School of Medicine.

Researchers at the School of Medicine have received three grants totaling more than $10 million to study the factors that contribute to deterioration in driving skills in older adults and to determine ways to identify people whose driving skills have begun to decline or are on the verge of slipping.

Faisal Ahmad, a second-year medical student at Washington University School of Medicine in St. Louis, is one of 55 recipients of a $5,000 summer research fellowship from the Alpha Omega Alpha National Honor Medical Society.

Nico Dosenbach, MD, PhD, at the School of Medicine, conducted research over six years on a patient who suffered a stroke as a newborn. The case study show “the brain’s remarkable resiliency to rewire itself.”

The Big Ideas 2021-2022 competition is open. The program provides opportunities for collaborative teams to develop innovations in informatics and health-care delivery The deadline to submit a letter of intent is March 29.

A worldwide clinical trial aimed at finding treatments for Alzheimer’s disease has expanded to include investigational drugs targeting a harmful form of the brain protein tau. The trial is led by Washington University School of Medicine.

A foodborne fungus that is harmless to most people exacerbates gastrointestinal symptoms in people with Crohn’s disease by preventing intestinal ulcers from healing, according to a new study from the School of Medicine and the Cleveland Clinic.